IV, intravenous SK, streptokinase SQ, subcutaneous. All patients also received chewable aspirin and heparin.īTwo-tailed P value is for comparison of Accelerated Activase to the respective SK control arm. Entry criteria for this international, multi-center trial included onset of chest pain within 6 hours of treatment and ST-segment elevation of ECG.Ĭonsider the results for the primary endpoint of the study, 30-day mortality, as well as secondary endpoints: EventĪIV and SQ refer to heparin route of administration. ![]() ![]() ![]()
0 Comments
Leave a Reply. |